Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 February 2023 | Story Kekeletso Takang | Photo Supplied
Michelle De Lange
UFS School of Accountancy Lecturer, Michelle de Lange, aced the recent Chartered Global Management Accountants Board exam, obtaining second position.

Michelle de Lange, accredited Accounting Lecturer in the School of Accountancy at the University of the Free State (UFS), finished second in the world at the recent Chartered Global Management Accountant (CGMA) Board Examination. With only one point between De Lange and the first candidate, she aced the challenging exam.    

Having obtained fourth position in the world for the 2019 CIMA Gateway exam, De Lange was determined to outdo herself.

The Chartered Institute of Management Accountants (CIMA) is the world’s largest global professional management accounting body to offer training and qualification in management accountancy. As designation holders, members get to showcase their skills and experience to a global audience, while upholding professionalism and promoting continuous learning. 

De Lange, who holds another professional accreditation from the South African Institute of Chartered Accountants (SAICA), coordinates the BCom Honours in Management Accounting programme, which is CIMA-aligned for postgraduate students. For De Lange, the greatest reward is the realisation of the impact she is making on her students through strategic vision.  

Having worked in the private sector and later joining the UFS as an Assistant Director at Finance back in 2016, De Lange believed that something was missing; that there was more to give. In 2018 she moved to the School of Accountancy, taking on her new role as Lecturer. “I wanted to make a difference and be significant. This motivated my move to lecturing,” she says. 

Her passion for teaching extends beyond the lecture hall. De Lange pays it forward by supporting students through a hands-on approach and ensuring that assessments are CIMA-aligned. 

The School of Accountancy in the Faculty of Economic and Management Sciences is proud of De Lange and her achievements. 

Becoming a CGMA requires discipline. De Lange is grateful for the support she received in preparation for the board exam, in particular from her husband Francois, who was “always understanding and encouraging”. 

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept